Capmatinib Active Not Recruiting Phase 2 Trials for Advanced Hepatocellular Carcinoma With c-MET Dysregulation Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01737827Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.